Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Sell
177
-39
-18% -$5.18K ﹤0.01% 846
2026
Q1
$33.6K Buy
216
+157
+266% +$28.2K ﹤0.01% 683
2025
Q4
$10.6K Buy
59
+3
+5% +$568 ﹤0.01% 788
2025
Q3
$10.6K Buy
56
+17
+44% +$2.96K ﹤0.01% 796
2025
Q2
$6.15K Buy
39
+13
+50% +$1.92K ﹤0.01% 865
2025
Q1
$3.51K Buy
26
+2
+8% +$279 ﹤0.01% 943
2024
Q4
$3.46K Buy
24
+16
+200% +$2.66K ﹤0.01% 924
2024
Q3
$1.3K Buy
8
+3
+60% +$454 ﹤0.01% 1037
2024
Q2
$729 Hold
5
﹤0.01% 1116
2024
Q1
$655 Hold
5
﹤0.01% 1022
2023
Q4
$541 Buy
+5
New +$509 ﹤0.01% 1013
2023
Q3
Sell
-5
Closed -$442 631
2023
Q2
$442 Sell
5
-55
-92% -$4.69K ﹤0.01% 986
2023
Q1
$5.52K Sell
60
-15
-20% -$1.45K ﹤0.01% 764
2022
Q4
$7.89K Sell
75
-65
-46% -$6.66K ﹤0.01% 684
2022
Q3
$12K Sell
140
-20
-13% -$1.95K ﹤0.01% 607
2022
Q2
$16K Hold
160
﹤0.01% 575
2022
Q1
$17K Hold
160
﹤0.01% 595
2021
Q4
$14K Buy
+160
New +$15K ﹤0.01% 589
2021
Q3
Sell
-130
Closed -$13K 632
2021
Q2
$13K Buy
130
+15
+13% +$1.54K ﹤0.01% 603
2021
Q1
$11K Buy
+115
New +$11.6K ﹤0.01% 514

Other funds holding LDOS

CVA Family Office's LDOS Position: Q2 2026 in Review

CVA Family Office reduced its Leidos (LDOS) stake by 18% in Q2 2026, selling an estimated $5.18K and leaving 177 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #846.

CVA Family Office first reported a position in LDOS in Q1 2021 and has held it in 20 quarters since. The position peaked at $33.6K in Q1 2026. 768 funds tracked by Wall St. Rank hold LDOS as of Q2 2026.

  • CVA Family Office held 177 shares of Leidos worth $18.2K as of Q2 2026.
  • CVA Family Office sold 39 Leidos shares in Q2 2026, an estimated $5.18K.
  • Leidos made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #846 holding.
  • CVA Family Office first reported a position in Leidos in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's Leidos position peaked at $33.6K in Q1 2026.
  • 768 funds tracked by Wall St. Rank held Leidos as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.